Published in Vaccine Weekly, November 1st, 1999
In their study, A.A. Belperron and colleagues compared the ability of two vaccines, both made of DNA that codes for a protein (known as SERA) that appears on the surface of the malaria parasite during several stages in its life cycle, to elicit an immune response against the parasite in mice. The first vaccine consisted simply of DNA suspended in a saline solution that was injected into the leg while the second used a device called a gene gun to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.